APA Цитирование

Drago, J., Formisano, L., Juric, D., Niemierko, A., Servetto, A., Wander, S., . . . Bardia, A. (2019). FGFR1 gene amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor positive (HR+) breast cancer. Clin Cancer Res.

Chicago-стиль цитирования

Drago, Josh, et al. "FGFR1 Gene Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor Positive (HR+) Breast Cancer." Clin Cancer Res 2019.

MLA-цитирование

Drago, Josh, et al. "FGFR1 Gene Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor Positive (HR+) Breast Cancer." Clin Cancer Res 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.